Canagliflozin Audit DUK Liverpool, 2019 - Abstract
Two year metabolic outcomes in the Association of British Clinical Diabetologist (ABCD) Nationwide Canagliflozin Audit: a comparison of glycaemic improvements
Dr A Puttanna*1, Dr M Yadagiri1, Dr P Sen Gupta1, Dr IW Gallen2, Dr A Bickerton3, Dr S Phillips4, Dr A Evans4, Dr D Sennik5, Dr REJ Ryder1, ABCD nationwide canagliflozin audit contributors6
1Diabetes and Endocrinology, Sandwell and West Birmingham NHS Trust, Birmingham, UK
2Diabetes and Endocrinology, Royal Berkshire Hospitals NHS Trust, Berkshire, UK
3Diabetes and Endocrinology, Yeovil District Hospital NHS Trust, Yeovil, UK
4Diabetes and Endocrinology, Cheltenham General Hospital, Cheltenham, UK
5Diabetes and Endocrinology, Princess Alexandra Hospital, Harlow, UK
6ABCD Nationwide Canagliflozin Audit contributors, UK
